These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation. Minami Y, Kitai S, Kudo M. Eur J Radiol; 2012 Mar; 81(3):e277-80. PubMed ID: 21392916 [Abstract] [Full Text] [Related]
6. Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography. Lee MW, Lim HK, Rhim H, Cha DI, Kang TW, Song KD, Min JH, Gwak GY, Kim S, Lu DSK. Can J Gastroenterol Hepatol; 2018 Mar; 2018():7926923. PubMed ID: 30013957 [Abstract] [Full Text] [Related]
7. Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. Rhim H, Lee MH, Kim YS, Choi D, Lee WJ, Lim HK. AJR Am J Roentgenol; 2008 May; 190(5):1324-30. PubMed ID: 18430851 [Abstract] [Full Text] [Related]
8. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography. Rhim H, Choi D, Kim YS, Lim HK, Choe BK. Eur J Radiol; 2010 Aug; 75(2):253-8. PubMed ID: 19427152 [Abstract] [Full Text] [Related]
11. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography. Park HJ, Lee MW, Rhim H, Cha DI, Kang TW, Lim S, Song KD, Lim HK. Clin Radiol; 2015 Apr; 70(4):387-94. PubMed ID: 25582889 [Abstract] [Full Text] [Related]
12. Contrast-enhanced ultrasound-guided radiofrequency ablation in inconspicuous hepatocellular carcinoma on B-mode ultrasound. Kim EJ, Kim YS, Shin SK, Kwon OS, Choi DJ, Kim JH. Turk J Gastroenterol; 2017 Nov; 28(6):446-452. PubMed ID: 29086712 [Abstract] [Full Text] [Related]
14. Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography. Makino Y, Imai Y, Ohama H, Igura T, Kogita S, Sawai Y, Fukuda K, Takamura M, Ohashi H, Murakami T. Oncology; 2013 Nov; 84 Suppl 1():44-50. PubMed ID: 23428858 [Abstract] [Full Text] [Related]
15. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography. Kim AY, Lee MW, Rhim H, Cha DI, Choi D, Kim YS, Lim HK, Cho SW. Korean J Radiol; 2013 Nov; 14(5):754-63. PubMed ID: 24043968 [Abstract] [Full Text] [Related]
16. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. Ahn SJ, Lee JM, Lee DH, Lee SM, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK. J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284 [Abstract] [Full Text] [Related]
17. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes. Song KD, Lee MW, Rhim H, Kang TW, Cha DI, Sinn DH, Lim HK. Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771 [Abstract] [Full Text] [Related]